Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

Inflammation tends to remain in people with psoriasis, despite their skin responding well to treatment with biologics, latest ...

A new study highlights a significant medical concern for individuals suffering from psoriasis, revealing that even when skin ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

By Dennis Thompson HealthDay ReporterTHURSDAY, May 29, 2025 (HealthDay News) — Belly flab appears to be a stronger warning ...

In a country where chronic skin diseases affect millions, one institution is rewriting the rulebook. Kayakalp Global, based ...

Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...

Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than ...

BELLY fat increases your risk of the skin condition psoriasis, a study warns. Psoriasis, which affects one in 50 people – ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Psoriasis is a chronic inflammatory skin condition that can impact quality of life. Many individuals with psoriasis also have ...